Evidence map›Paper›PMID 39720399›Full record

ArticleThe Pan African medical journal2024

"Are we ready to transition from the Global Alliance for Vaccines and Immunization support?" Perceptions from 15 Kenyan counties.

Alex Olateju Adjagba, James Odhiambo Oguta, Elvis Omondi Achach Wambiya, Caleb Nyakundi, Sharonmercy Okemwa, Catherine Akoth

Abstract read
In one paragraph

Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Who will pay for the malaria vaccines in Africa?Archives of public health = Archives belges de sante publique · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alex Olateju AdjagbaUniversity of Western Cape, Cape Town, South Africa.
James Odhiambo OgutaHealth Section, UNICEF, Eastern and Southern Africa Regional Office, Nairobi, Kenya.
Elvis Omondi Achach WambiyaDivision of Population Health, Sheffield Centre for Health and Related Research, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.
Caleb NyakundiMoi University, School of Nursing, Eldoret, Kenya.
Sharonmercy OkemwaMoi University, School of Nursing, Eldoret, Kenya.
Catherine AkothDivision of Population Health, Sheffield Centre for Health and Related Research, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Gavi, the Vaccine Alliance, defined a transition roadmap for countries receiving funding support based on their income status projections. According to the latest projections, Kenya will complete their transition from vaccine funding in 2029. While eligible countries are kept informed and supported for a smooth transition process, the extent to which countries understand the significant implications of a complete end of GAVI support on immunization service delivery varies. Furthermore, whereas studies have been conducted to assess national preparedness for transition, there is a paucity of data on the understanding of subnational authorities of this process. In this study, we explored the perspectives of county-level stakeholders on Kenya's preparedness for GAVI transition. Methods: using purposive sampling, 77 senior county officials from 15 counties were selected for in-depth interviews. Data were collected using a semi-structured interview guide, transcribed, and thematically analysed. Ethical approval for the study was granted by Moi University Institutional Ethics and Research Committee. Results: findings reveal a consensus among respondents that both national and county governments are not fully prepared for the end of the Gavi Alliance. Concerns were highlighted around a lack of knowledge about vaccine costs, post-transition funding sources, and potential disruptions in immunization services. Respondents advocated for a phased transition, continued donor support, clear funding allocation, and legislative measures to ensure financial sustainability. Moreover, advocacy and awareness efforts, capacity building, and a robust legal framework were emphasized as essential for a smooth transition. Conclusion: after the end of the financial support provided by Gavi Alliance, Kenya's immunization bill is expected to be significant. This study underscores the importance of effectively engaging the subnational (county) level authorities. Successful transition from Gavi's support requires a strategy that promotes awareness and improves communication regarding the expected impact of the impending transition from Gavi on sustainable immunization financing in Kenya.

Indexed as

Immunization ProgramsInterviews as TopicVaccinesDelivery of Health CareHumansImmunizationInternational CooperationKenyaVaccinationVaccinescountyfundingGAVI AllianceimmunizationKenyasubnationaltransition

Identifiers

PMID39720399
PMCPMC11667085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.